Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.690
-0.030 (-1.74%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
+0.010 (0.59%)
After-hours: Apr 28, 2026, 7:16 PM EDT
Tempest Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 24 | 14 | 36 | 85 | 12 | 36 | |
| Market Cap Growth | 10.71% | -61.17% | -57.00% | 600.22% | -66.85% | - | |
| Enterprise Value | 25 | 15 | 32 | 95 | -14 | -4 | |
| Last Close Price | 1.69 | 2.87 | 10.85 | 57.20 | 14.95 | 68.64 | |
| PB Ratio | 1.25 | 2.12 | 1.90 | 3.16 | 0.67 | 1.01 | |
| P/TBV Ratio | 3.64 | 2.12 | 1.90 | 3.16 | 0.67 | 1.01 | |
| Debt / Equity Ratio | 1.22 | 1.22 | 0.80 | 0.77 | 1.22 | 0.51 | |
| Net Debt / Equity Ratio | 0.07 | 0.07 | -0.78 | -0.69 | -0.50 | -0.92 | |
| Net Debt / EBITDA Ratio | -0.02 | -0.02 | 0.36 | 0.65 | 0.27 | 1.25 | |
| Net Debt / FCF Ratio | -0.02 | -0.02 | 0.45 | 0.68 | 0.29 | 1.28 | |
| Quick Ratio | 2.33 | 2.33 | 2.13 | 4.17 | 4.29 | 2.59 | |
| Current Ratio | 2.50 | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 | |
| Return on Equity (ROE) | -203.63% | -203.63% | -182.35% | -131.42% | -131.70% | -104.76% | |
| Return on Assets (ROA) | -56.86% | -56.86% | -56.43% | -37.31% | -36.29% | -35.10% | |
| Return on Capital Employed (ROCE) | -195.20% | -195.20% | -154.10% | -69.10% | -89.30% | -50.70% | |
| Earnings Yield | -108.34% | -185.72% | -114.89% | -34.82% | -295.25% | -77.57% | |
| FCF Yield | -110.64% | -189.66% | -91.88% | -32.50% | -261.55% | -71.51% | |
| Buyback Yield / Dilution | -93.35% | -93.35% | -80.99% | -33.49% | -204.70% | -709.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.